Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11369301 | 0.89 | GAA (0.33) | PABPC1CTDSP1GAA | |
| SCHEMBL16161520 | 0.88 | PABPC1 (0.33) | PABPC1CTDSP1GAA | |
| SCHEMBL22518250 | 0.86 | PABPC1 (0.33) | PABPC1CTDSP1GAA | |
| SCHEMBL16161478 | 0.85 | TERT (0.33) | PABPC1CTDSP1GAA | |
| SCHEMBL16161408 | 0.85 | CHRM1 (0.32) | PABPC1CTDSP1GAA | |
| SCHEMBL23083343 | 0.83 | CHRM1 (0.32) | — | |
| SCHEMBL7911823 | 0.83 | TERT (0.33) | — | |
| SCHEMBL14575730 | 0.83 | TERT (0.33) | — | |
| SCHEMBL17364598 | 0.83 | TERT (0.33) | — | |
| SCHEMBL17364599 | 0.83 | TERT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| EP-2555742-B2 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2018-12-05 | — | — | EP | claimed |
| US-10113140-B2 | Freshening compositions and devices comprising same | THE PROCTER & GAMBLE COMPANY (US) | 2018-10-30 | — | — | US | claimed |
| US-20180004875-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2018-01-04 | — | — | US | claimed |
| US-20170333591-A9 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2017-11-23 | — | — | US | claimed |
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| EP-3197422-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| EP-3197508-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-02 | — | — | EP | claimed |
| EP-2556139-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-08-02 | — | — | EP | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-8822402-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-02 | — | — | US | claimed |
| US-8633148-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2014-01-21 | — | — | US | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| EP-2555742-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2013-02-13 | — | — | EP | claimed |
| EP-2556139-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2013-02-13 | — | — | EP | claimed |
| WO-2011127030-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-13 | — | — | WO | claimed |
| WO-2011127011-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-13 | — | — | WO | claimed |
| US-20110245134-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2011-10-06 | — | — | US | claimed |
| US-20110245136-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2011-10-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | PABPC1 2144/4885CTDSP1 3511/4885GAA 853/4885 |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | PABPC1 2123/4885CTDSP1 3474/4885GAA 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.